Low‐dose decitabine improved the polarization of macrophages in vitro and in vivo, and low‐dose DAC promoted M2 macrophage polarization due to the demethylation within the promoter of PPARγ thus enhancing KLF4 binding affinity in ITP. The gene discussed is KLF4; the disease is autoimmune thrombocytopenic purpura.